Inactive Instrument
Ibere Pharmaceuticals Stock
Stocks
IBER
KYG468431013
Investment Holding Companies
| 1 day | -0.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Osagie Imasogie
CEO | Chief Executive Officer | 64 | - |
Lisa Gray
DFI | Director of Finance/CFO | 61 | - |
Zoltan Kerekes
COO | Chief Operating Officer | 60 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osagie Imasogie
CHM | Chairman | 64 | - |
Lisa Gray
BRD | Director/Board Member | 61 | - |
Zoltan Kerekes
BRD | Director/Board Member | 60 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/2/21 A | Buy | Director | 10,000 | 0.0833% | ||
| 2/25/21 A | Pipv Capital
| Other | Company | 3,350,000 | - | |
| 2/25/21 A | Other | Director | 25,000 | 0.8333% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | +0.10% | - | - | 176M | |
| +0.42% | -11.40% | - | - | 671M | |
| -0.10% | +0.05% | - | - | 648M | |
| -0.10% | 0.00% | - | - | 601M | |
| -0.74% | -0.65% | - | - | 594M | |
| 0.00% | +0.05% | +2.12% | - | 592M | |
| -0.72% | -3.82% | +235.76% | -77.66% | 556M | |
| -0.27% | -2.62% | - | - | 552M | |
| -0.05% | -0.15% | - | - | 504M | |
| Average | -0.11% | -2.18% | +118.94% | -77.66% | 589.91M | |
| Weighted average by Cap. | -0.08% | -2.34% | +115.23% | -77.66% |
Employees
-
Sector
Investment Holding Companies
